Asthma in the Elderly: The Role of Vitamin D

Asthma in the Elderly Clinical Trial

Official title:

Asthma in the Elderly: The Role of Vitamin D

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01730976
• Other study ID #: F/N-R13-3217B
• Secondary ID: SSRF2012-01
• Status: Completed
• Phase: Phase 3
• First received: November 15, 2012
• Last updated: September 8, 2014
• Start date: November 2012
• Est. completion date: March 2013

Study information

• Verified date: September 2014
• Source: Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

We will study whether taking vitamin D improves asthma control and spirometric values in elderly asthmatics.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: March 2013
• Est. primary completion date: March 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Asthma, age of 65 years old or older

Exclusion Criteria:

• Current smokers, subjects who smoked more than 10 pack/year, subjects taking digoxin, subjects with liver disease

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Asthma
• Asthma in the Elderly

Intervention

Dietary Supplement:
• Vitamin D 2,000 I.U.

Locations

Country	Name	City	State
United States	Rohr and Columbo Asthma, Allergy and Immunology Specialists	Bryn Mawr	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Serum vitamin D and calcium levels		Three months	Yes
Primary	Improvement in Asthma Control Test (ACT) score		Three months	No
Secondary	Improvement in pulmonary function tests values (FEV1%, etc.)		Three months	No